Pramod
Gupta, PhD, SVP of Pharmaceutical Operations at Spectrum Pharmaceuticals will
be speaking on "Research Opportunities in Current Health Care
Environment".
Friday,
October 26th (Nevada Day)
11:30
check-in, 12 pm Lunch & Talk
McCormick
& Schmicks
$30
RSVP here
(UNLV
Students & Researchers - free! Please RSVP)
Spectrum
Pharmaceuticals (SPPI) is a biotechnology company with a primary focus in
oncology and hematology. Its headquarters is in Henderson, Nevada.
Spectrum
has three oncology drugs in the market: FUSILEV® (levoleucovorin), FOLOTYN®
(pralatrexate injection) and ZEVALIN® (ibritumomab tiuxetan).
Spectrum
has an expertise in acquiring differentiated drugs and a growing pipeline of
candidates in Phase 2 and Phase 3 trials (10 drugs in the pipeline).
Spectrum
Pharmaceuticals is one of the fastest growing companies in biotechnology. It
has a massive pipeline, two marketed drugs, and is very cash rich. (Brian
Nichols, Sept 2, 2012 Seeking Alpha). Spectrum's revenues are expected to
increase by 50% to $300 million in 2012.
1 comment:
If some one needs too be updated with newest technologies after that he
must be pay a quick visit this web page and be up to date
everyday.
Have a look at my blog - risingtidebook karaoke songs
Post a Comment